239 related articles for article (PubMed ID: 22446103)
1. Estrogen regulates JNK1 genomic localization to control gene expression and cell growth in breast cancer cells.
Sun M; Isaacs GD; Hah N; Heldring N; Fogarty EA; Kraus WL
Mol Endocrinol; 2012 May; 26(5):736-47. PubMed ID: 22446103
[TBL] [Abstract][Full Text] [Related]
2. SIRT1 represses estrogen-signaling, ligand-independent ERα-mediated transcription, and cell proliferation in estrogen-responsive breast cells.
Moore RL; Faller DV
J Endocrinol; 2013 Mar; 216(3):273-85. PubMed ID: 23169992
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol regulates the cell viability promoted by 17β-estradiol or bisphenol A via down-regulation of the cross-talk between estrogen receptor α and insulin growth factor-1 receptor in BG-1 ovarian cancer cells.
Kang NH; Hwang KA; Lee HR; Choi DW; Choi KC
Food Chem Toxicol; 2013 Sep; 59():373-9. PubMed ID: 23810794
[TBL] [Abstract][Full Text] [Related]
4. Activation of estrogen receptor α by raloxifene through an activating protein-1-dependent tethering mechanism in human cervical epithelial cancer cells: a role for c-Jun N-terminal kinase.
Fogarty EA; Matulis CK; Kraus WL
Mol Cell Endocrinol; 2012 Jan; 348(1):331-8. PubMed ID: 21964465
[TBL] [Abstract][Full Text] [Related]
5. Palmitoylation regulates 17β-estradiol-induced estrogen receptor-α degradation and transcriptional activity.
La Rosa P; Pesiri V; Leclercq G; Marino M; Acconcia F
Mol Endocrinol; 2012 May; 26(5):762-74. PubMed ID: 22446104
[TBL] [Abstract][Full Text] [Related]
6. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors.
Madak-Erdogan Z; Kieser KJ; Kim SH; Komm B; Katzenellenbogen JA; Katzenellenbogen BS
Mol Endocrinol; 2008 Sep; 22(9):2116-27. PubMed ID: 18617595
[TBL] [Abstract][Full Text] [Related]
7. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
8. Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs.
Madak-Erdogan Z; Lupien M; Stossi F; Brown M; Katzenellenbogen BS
Mol Cell Biol; 2011 Jan; 31(1):226-36. PubMed ID: 20956553
[TBL] [Abstract][Full Text] [Related]
9. Annexin-1 regulates growth arrest induced by high levels of estrogen in MCF-7 breast cancer cells.
Ang EZ; Nguyen HT; Sim HL; Putti TC; Lim LH
Mol Cancer Res; 2009 Feb; 7(2):266-74. PubMed ID: 19208747
[TBL] [Abstract][Full Text] [Related]
10. Differential induction of LRP16 by liganded and unliganded estrogen receptor alpha in SKOV3 ovarian carcinoma cells.
Tian L; Wu Z; Zhao Y; Meng Y; Si Y; Fu X; Mu Y; Han W
J Endocrinol; 2009 Jul; 202(1):167-77. PubMed ID: 19403568
[TBL] [Abstract][Full Text] [Related]
11. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
[TBL] [Abstract][Full Text] [Related]
12. Different epigenetic mechanisms of ERα implicated in the fate of fulvestrant-resistant breast cancer.
Tsuboi K; Kaneko Y; Nagatomo T; Fujii R; Hanamura T; Gohno T; Yamaguchi Y; Niwa T; Hayashi SI
J Steroid Biochem Mol Biol; 2017 Mar; 167():115-125. PubMed ID: 27888136
[TBL] [Abstract][Full Text] [Related]
13. Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36).
Chaudhri RA; Olivares-Navarrete R; Cuenca N; Hadadi A; Boyan BD; Schwartz Z
J Biol Chem; 2012 Mar; 287(10):7169-81. PubMed ID: 22247547
[TBL] [Abstract][Full Text] [Related]
14. PARP-1 Regulates Estrogen-Dependent Gene Expression in Estrogen Receptor α-Positive Breast Cancer Cells.
Gadad SS; Camacho CV; Malladi V; Hutti CR; Nagari A; Kraus WL
Mol Cancer Res; 2021 Oct; 19(10):1688-1698. PubMed ID: 34158394
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
[TBL] [Abstract][Full Text] [Related]
16. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M
Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451
[TBL] [Abstract][Full Text] [Related]
17. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
Ariazi EA; Brailoiu E; Yerrum S; Shupp HA; Slifker MJ; Cunliffe HE; Black MA; Donato AL; Arterburn JB; Oprea TI; Prossnitz ER; Dun NJ; Jordan VC
Cancer Res; 2010 Feb; 70(3):1184-94. PubMed ID: 20086172
[TBL] [Abstract][Full Text] [Related]
18. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
19. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
Al-Dhaheri MH; Rowan BG
Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]